Labetalol Hydrochloride Tablet, Film Coated
Product Images NDC 10135-712

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Labetalol Hydrochloride (NDC 10135-712). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Marlex Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Labetalol Hydrochloride, Usp Is A Racemate, Chemically Designated As 2-hydroxy-5-[1-hydroxy-2-[(1- Methyl-3-phenylpropyl)amino]ethyl] Benzamide Monohydrochloride, And It Has The Following Structure: (Labetalol Hydrochloride Tablets 01)

FDA Label Image

Principal Display Panelndc 10135-0711-01labetalol Hydrochloride Tablets, Usp 100 mgrx Only 100 Tablets (Labetalol Hydrochloride Tablets 02)

Each tablet of Labetalol Hydrochloride Tablets, USP contains 100 mg Labetalol USP. The usual dosage can be found on the package insert for prescribing information. The tablets contain Biperce, a beta-adrenergic blocking agent, and are resistant to heat and moisture. They come in a package of 100 tablets. Keep this medication out of reach of children. Manufacturer and distributor information is not available.*

FDA Label Image

Principal Display Panelndc 10135-0711-05labetalol Hydrochloride Tablets, Usp 100 mgrx Only 500 Tablets (Labetalol Hydrochloride Tablets 03)

MarLEX presents Labetalol Hydrochloride USP tablets of 100mg, in a bottle of 500 tablets. This medication is to be taken following the package instructions. It is important to keep the container tightly closed and in a cool, light-resistant place. It should be kept out of reach of children, and not used if the inner seal is broken or missing. Marlex Pharmaceuticals manufactures and distributes the tablets from New Castle, Delaware.*

FDA Label Image

Principal Display Panelndc 10135-0712-01labetalol Hydrochloride Tablets, Usp 200 mgrx Only 100 Tablets (Labetalol Hydrochloride Tablets 04)

DMARLEX is not available.*

FDA Label Image

Principal Display Panelndc 10135-0712-05labetalol Hydrochloride Tablets, Usp 200 mgrx Only 500 Tablets (Labetalol Hydrochloride Tablets 05)

Labetalol Hydrochloride Tablets, USP is a prescription medication used for its antihypertensive properties. Each tablet contains 200 mg of labetalol hydrochloride, and the usual dosage can be found in the package insert. The medication should be stored in a tightly sealed and light-resistant container at controlled room temperature, and the inner seal should not be broken or missing at the time of dispensing. This medication should be kept out of reach of children. The manufacturer and distributor of this medication are Marlex Pharmaceutical, Inc., located in New Castle, Delaware.*

FDA Label Image

Principal Display Panelndc 10135-0713-01labetalol Hydrochloride Tablets, Usp 300 mgrx Only 100 Tablets (Labetalol Hydrochloride Tablets 06)

FDA Label Image

Principal Display Panelndc 10135-0713-05labetalol Hydrochloride Tablets, Usp 300 mgrx Only 500 Tablets (Labetalol Hydrochloride Tablets 07)

This is a medication description for Labetalol Hydrochloride, USP 300mg tablets. The usual dosage information is not available and the package outsert should be read for full prescribing information. It should be stored in a tight, light-resistant container at 20° to 25° Celsius (68°F to 77°F) as defined by USP Controlled Room Temperature. The inner seal on the bottle should not be used if it is broken or missing, and the medication should be kept out of reach of children. This medication is available by prescription only and is manufactured and distributed by Marex Pharmaceuticals, Inc. in New Castle, Delaware.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.